881404-62-2

Basic information

• Product Name: 1,2,3,9-TETRAHYDRO-2-METHYL-PYRROLO[2,1-B]QUINAZOLINE
• Synonyms: 1,2,3,9-TETRAHYDRO-2-METHYL-PYRROLO[2,1-B]QUINAZOLINE;2-Methyl-1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline
• CAS NO: 881404-62-2
• Molecular Formula: C12H14 N2
• Molecular Weight: 186.25
• Mol File: 881404-62-2.mol

Chemical Properties

• Boiling Point: 315.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.20±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 9.76±0.40(Predicted)
• CAS DataBase Reference: 1,2,3,9-TETRAHYDRO-2-METHYL-PYRROLO[2,1-B]QUINAZOLINE(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2,3,9-TETRAHYDRO-2-METHYL-PYRROLO[2,1-B]QUINAZOLINE(881404-62-2)
• EPA Substance Registry System: 1,2,3,9-TETRAHYDRO-2-METHYL-PYRROLO[2,1-B]QUINAZOLINE(881404-62-2)

Safety Data

• Hazardous Substances Data: 881404-62-2(Hazardous Substances Data)

Usage

Chemical Family

Pyrroloquinazoline derivatives

Explanation

The compound belongs to a group of chemical compounds that have a fused pyrrole and quinazoline ring structure.

Explanation

It is a compound with a ring structure containing both carbon and non-carbon atoms.

Explanation

The compound has a distinctive structure formed by the fusion of a pyrrole ring and a quinazoline ring.

Explanation

The compound may have uses in the development of drugs due to its ability to interact with various biological targets.

Explanation

The compound can potentially bind to and modulate the activity of receptors and enzymes, which are important for various biological processes.

Explanation

The compound may have therapeutic potential in treating neurological disorders and cancer due to its ability to modulate neurotransmitter systems and inhibit cell growth.

Explanation

More research is needed to fully understand the compound's potential in drug development and medical applications.

Explanation

The compound is composed of 11 carbon atoms, 12 hydrogen atoms, and 2 nitrogen atoms.

Explanation

The molecular weight is the sum of the atomic weights of all the atoms in the molecule.

Explanation

The solubility of the compound in various solvents is not provided in the material.

Explanation

The stability of the compound under different conditions is not provided in the material.

Explanation

No alternative names or synonyms for the compound are mentioned in the material.

Heterocyclic Compound

Yes

Unique Structure

Pyrrole and quinazoline ring

Pharmaceutical Applications

Potential

Interaction with Biological Targets

Receptors and enzymes

Therapeutic Potential

Neurological disorders and cancer

Further Research

Required

Molecular Weight

Approximately 172.23 g/mol

Solubility

Unknown

Stability

Unknown

Synonyms

None provided

Upstream product

• 552-89-6 2-nitro-benzaldehyde 
• 174536-41-5 N-(2'-methylprop-2'-enyl)-2-nitrobenzylamine 
• 1904-64-9 3,4-dihydroquinazoline 
• 201230-82-2 carbon monoxide 
• 174536-45-9 2-amino-N-(2'-methylprop-2'-enyl)benzylamine 

Relevant articles and documents

Rhodium-catalyzed direct C-H addition of 3,4-dihydroquinazolines to alkenes and their use in the total synthesis of vasicoline

The inter- and intramolecular couplings of unactivated alkenes to 3,4-dihydroquinazolines with a Rh(I) catalyst are reported. Coupling between olefins and NH-3,4-dihydroquinazoline was found to occur consecutively with heterocycle dehydrogenation in the p

The Stereochemistry of Organometallic Compounds. XLII. The Preparation of Quinazolines Involving Rhodium-Catalysed Hydroformylation of 2-Amino-N-alkenylbenzylamines

Rhodium-catalysed reactions of 2-amino-N-alkenylbenzylamines with H2/CO give hexahydropyrrolo- and hexahydropyridoquinazolines.Reactions of N-allyl derivatives give a single regioisomer, and reactions of but-3-enyl analogues give mixtures of pyrrol